Date published: 2026-3-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

TAF1L Inhibitors

The chemical class known as TAF1L Inhibitors comprises a group of compounds meticulously designed to selectively target the molecular entity TAF1L. TAF1L, or TATA-Box Binding Protein Associated Factor 1-Like, is a member of the TAF family involved in the assembly and functioning of the RNA polymerase II transcription initiation complex. This complex is pivotal for initiating the transcription of protein-coding genes in eukaryotic cells. While TAF1L's role in transcriptional regulation is acknowledged, the specific functions and interactions within this context remain subjects of active investigation. Inhibitors within the TAF1L Inhibitors class are intricately engineered molecules with the primary objective of modulating the activity or function of TAF1L, thereby inducing an inhibitory effect. Researchers engaged in this field utilize a multifaceted approach, integrating insights from structural biology, medicinal chemistry, and computational modeling to unravel the complex molecular interactions between the inhibitors and the target TAF1L.

Structurally, TAF1L Inhibitors are characterized by specific molecular features designed to facilitate selective binding to TAF1L. This selectivity is crucial to minimize unintended effects on other cellular components, ensuring a focused impact on the intended molecular target. The development of inhibitors within this chemical class involves a comprehensive exploration of structure-activity relationships, optimization of pharmacokinetic properties, and a deep understanding of the molecular mechanisms associated with TAF1L. As researchers delve deeper into the functional aspects of TAF1L Inhibitors, the knowledge generated contributes not only to deciphering the specific roles of TAF1L but also to advancing our broader comprehension of the intricate processes governing gene expression and transcriptional regulation within cells. The exploration of TAF1L Inhibitors stands as a significant avenue for expanding fundamental knowledge in molecular pharmacology and cellular biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

A macrolide compound that inhibits mTOR, a key regulator of protein synthesis and cell growth, potentially affecting TAF1L expression indirectly.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, thus potentially reducing TAF1L levels post-transcriptionally.

Mifepristone

84371-65-3sc-203134
100 mg
$61.00
17
(1)

Glucocorticoid receptor antagonist that may alter transcription factor activity, potentially affecting TAF1L expression indirectly.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

A CDK inhibitor that can inhibit transcription elongation by RNA polymerase II, possibly leading to reduced TAF1L mRNA synthesis.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

A diterpene triepoxide that inhibits the activity of RNA polymerase I, II, and III, thus could decrease the transcription of TAF1L.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Binds to DNA and inhibits RNA polymerase movement, potentially decreasing TAF1L transcription.

Chidamide

743420-02-2sc-364462
sc-364462A
sc-364462B
1 mg
5 mg
25 mg
$62.00
$250.00
$1196.00
(1)

Disrupts the structure of p300 and CREB binding protein (CBP), which are histone acetyltransferases involved in the regulation of transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that can cause DNA hypomethylation and potentially affect gene expression, including TAF1L.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

A histone deacetylase inhibitor that can change gene expression by affecting chromatin structure and access of transcription machinery.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

A CDK4/6 inhibitor which can arrest cell cycle progression and influence transcription factor activity and gene expression.